These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 16762728)

  • 1. Heat shock protein-based cancer vaccines.
    Lee KP; Raez LE; Podack ER
    Hematol Oncol Clin North Am; 2006 Jun; 20(3):637-59. PubMed ID: 16762728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in heat shock protein-based cancer vaccines.
    Wang HH; Mao CY; Teng LS; Cao J
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein vaccines: from bench to bedside.
    Binder RJ
    Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current ideas about applications of heat shock proteins in vaccine design and immunotherapy.
    Wang XY; Li Y; Yang G; Subjeck JR
    Int J Hyperthermia; 2005 Dec; 21(8):717-22. PubMed ID: 16338854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.
    Murshid A; Gong J; Calderwood SK
    Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heat shock proteins, immune competence and vaccination].
    Milani V; Endres M; Kuppner MC; Issels RD; Noessner E
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):31-5. PubMed ID: 14703579
    [No Abstract]   [Full Text] [Related]  

  • 7. Hsp-based tumor vaccines: state-of-the-art and future directions.
    Takakura Y; Takemoto S; Nishikawa M
    Curr Opin Mol Ther; 2007 Aug; 9(4):385-91. PubMed ID: 17694451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock proteins in glioblastomas.
    Yang I; Fang S; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How is the immune response affected by hyperthermia and heat shock proteins?
    Calderwood SK; Theriault JR; Gong J
    Int J Hyperthermia; 2005 Dec; 21(8):713-6. PubMed ID: 16338853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
    Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein derivatives for delivery of antigens to antigen presenting cells.
    Nishikawa M; Takemoto S; Takakura Y
    Int J Pharm; 2008 Apr; 354(1-2):23-7. PubMed ID: 17980980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-shock proteins as powerful weapons in vaccine development.
    Bolhassani A; Rafati S
    Expert Rev Vaccines; 2008 Oct; 7(8):1185-99. PubMed ID: 18844593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp receptors: the cases of identity and mistaken identity.
    Binder RJ
    Curr Opin Mol Ther; 2009 Feb; 11(1):62-71. PubMed ID: 19169961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock proteins and their use as anticancer vaccines.
    Parmiani G; Testori A; Maio M; Castelli C; Rivoltini L; Pilla L; Belli F; Mazzaferro V; Coppa J; Patuzzo R; Sertoli MR; Hoos A; Srivastava PK; Santinami M
    Clin Cancer Res; 2004 Dec; 10(24):8142-6. PubMed ID: 15623587
    [No Abstract]   [Full Text] [Related]  

  • 16. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
    Ge W; Li Y; Li ZS; Zhang SH; Sun YJ; Hu PZ; Wang XM; Huang Y; Si SY; Zhang XM; Sui YF
    Cancer Immunol Immunother; 2009 Feb; 58(2):201-8. PubMed ID: 18523770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secreted heat shock protein gp96-Ig: an innovative vaccine approach.
    Strbo N; Podack ER
    Am J Reprod Immunol; 2008 May; 59(5):407-16. PubMed ID: 18405311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice.
    Liang J; Aihua Z; Yu W; Jingjing L
    Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):541-8. PubMed ID: 18473288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell-based cancer immunotherapies.
    Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
    Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scavenger receptor-A negatively regulates antitumor immunity.
    Wang XY; Facciponte J; Chen X; Subjeck JR; Repasky EA
    Cancer Res; 2007 May; 67(10):4996-5002. PubMed ID: 17510431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.